Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02436356 · ClinicalTrials.gov registry record · NA
New Tools for Assessing Fracture Risk
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02436356 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 48 participants.
The verdict
NCT02436356, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether two new, non-X-ray techniques can discriminate between high-energy fractures of normal bone (trauma) and low-energy fractures (fragility) of osteoporotic bone. The current gold-standard for assessing fracture risk areal bone mineral density (aBMD) by dual energy X-ray absorptiometry (DXA) is not particularly effective at identifying individuals who are at risk of suffering a fracture. Yet, there is a growing population of diabetics and elderly individuals prone to fractures. In effect, the age-related and diabetes-related increase in fracture risk is independent of a person's aBMD. These findings stress the urgency in developing diagnostic tools that can improve fracture risk prediction so that patients can be treated with the appropriate anti-fracture therapies.
Interventions
- RADIATION MRI
- DEVICE Osteoprobe-Reference Point Indentation (RPI)
- RADIATION Dual-energy X-ray absorptiometry (DXA) Scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-06-30 |
| Est. Completion | 2018-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02436356
The ClinicalTrials.gov registry entry for NCT02436356 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MRI is the first listed.
NCT02436356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02436356 about?
NCT02436356 is a clinical study titled "New Tools for Assessing Fracture Risk". The goal of this study is to determine whether two new, non-X-ray techniques can discriminate between high-energy fractures of normal bone (trauma) and low-energy fractures (fragility) of osteoporotic bone. The current gold-standard for assessing fracture risk areal bone mineral density (aBMD) by du...
What is the current status of trial NCT02436356?
This trial is currently terminated. It is a NA study. The enrollment target is 48 participants. The study started on 2015-06-30. Estimated completion is 2018-11-08.
What interventions are being tested in trial NCT02436356?
The interventions under investigation include: MRI (RADIATION), Osteoprobe-Reference Point Indentation (RPI) (DEVICE), Dual-energy X-ray absorptiometry (DXA) Scans (RADIATION).
Who is sponsoring clinical trial NCT02436356?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.